{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:36:54Z","timestamp":1792136214013,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00833-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:47:02Z","timestamp":1778482022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ensemble learning-guided discovery of anti-tuberculosis phytochemicals: computational prediction and mechanistic insights"],"prefix":"10.1007","volume":"40","author":[{"given":"Harshit","family":"Sajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-6678","authenticated-orcid":false,"given":"Anuroopa G.","family":"Nadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"833_CR1","unstructured":"who.int [Internet] (2025) Tuberculosis. In: World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed 25 Jan 2026"},{"key":"833_CR2","doi-asserted-by":"publisher","first-page":"107861","DOI":"10.1016\/j.micpath.2025.107861","volume":"206","author":"M Sikandar","year":"2025","unstructured":"Sikandar M, Xing L (2025) Advances in the mechanisms of drug resistance of Mycobacterium tuberculosis. Microb Pathog 206:107861. https:\/\/doi.org\/10.1016\/j.micpath.2025.107861","journal-title":"Microb Pathog"},{"key":"833_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/metabo11020088","volume":"11","author":"DPS Chang","year":"2021","unstructured":"Chang DPS, Guan XL (2021) Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy. Metabolites 11:88. https:\/\/doi.org\/10.3390\/metabo11020088","journal-title":"Metabolites"},{"key":"833_CR4","doi-asserted-by":"publisher","unstructured":"Sharma D, Anabala M, Jain VV et al (2025) Computational landscape in drug discovery: from AI\/ML models to translational application. Scientifica (Cairo) 2025(1688637). https:\/\/doi.org\/10.1155\/sci5\/1688637","DOI":"10.1155\/sci5\/1688637"},{"key":"833_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11281-9","author":"H Sajal","year":"2025","unstructured":"Sajal H, Mishra S (2025) An innovative machine learning-based QSAR approach for prediction and structural analysis of novel\/repurposed acid ceramidase (ASAH1) inhibitors for glioblastoma therapy. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-025-11281-9","journal-title":"Mol Divers"},{"key":"833_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jep.2018.08.031","volume":"227","author":"VK Gupta","year":"2018","unstructured":"Gupta VK, Kaushik A, Chauhan DS et al (2018) Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. J Ethnopharmacol 227:113\u2013120. https:\/\/doi.org\/10.1016\/j.jep.2018.08.031","journal-title":"J Ethnopharmacol"},{"key":"833_CR7","doi-asserted-by":"publisher","first-page":"102082","DOI":"10.1016\/j.scp.2025.102082","volume":"46","author":"R Chelliah","year":"2025","unstructured":"Chelliah R, Vijayalakshmi S, Karuvelan M et al (2025) Revitalizing natural products for sustainable drug Discovery: Innovations bridging food bioscience and green therapeutic development. Sustain Chem Pharm 46:102082. https:\/\/doi.org\/10.1016\/j.scp.2025.102082","journal-title":"Sustain Chem Pharm"},{"key":"833_CR8","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1007\/s11831-023-09933-w","volume":"30","author":"F Ali","year":"2023","unstructured":"Ali F, Kumar H, Alghamdi W et al (2023) Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides. Arch Comput Methods Eng 30:4033\u20134044. https:\/\/doi.org\/10.1007\/s11831-023-09933-w","journal-title":"Arch Comput Methods Eng"},{"key":"833_CR9","doi-asserted-by":"publisher","first-page":"57448","DOI":"10.1021\/acsomega.5c07750","volume":"10","author":"N Schaduangrat","year":"2025","unstructured":"Schaduangrat N, Mookdarsanit P, Mahmud SMH et al (2025) XAI-ACSM: An ensemble-based explainable artificial intelligence framework for the accurate prediction of anticancer small molecules. ACS Omega 10:57448\u201357462. https:\/\/doi.org\/10.1021\/acsomega.5c07750","journal-title":"ACS Omega"},{"key":"833_CR10","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","volume":"8","author":"RP Vivek-Ananth","year":"2023","unstructured":"Vivek-Ananth RP, Mohanraj K, Sahoo AK, Samal A (2023) IMPPAT 2.0: an enhanced and expanded phytochemical atlas of indian medicinal plants. ACS Omega 8:8827\u20138845. https:\/\/doi.org\/10.1021\/acsomega.3c00156","journal-title":"ACS Omega"},{"key":"833_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1021\/ci100176x","volume":"50","author":"D Fourches","year":"2010","unstructured":"Fourches D, Muratov E, Tropsha A (2010) Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50:1189\u20131204. https:\/\/doi.org\/10.1021\/ci100176x","journal-title":"J Chem Inf Model"},{"key":"833_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13321-019-0353-8","volume":"11","author":"D Gadaleta","year":"2019","unstructured":"Gadaleta D, Lombardo A, Toma C, Benfenati E (2019) Correction to: A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications. J Cheminform 11:31. https:\/\/doi.org\/10.1186\/s13321-019-0353-8","journal-title":"J Cheminform"},{"key":"833_CR13","doi-asserted-by":"publisher","first-page":"6675279","DOI":"10.1155\/2021\/6675279","volume":"2021","author":"SK Hussin","year":"2021","unstructured":"Hussin SK, Abdelmageid SM, Alkhalil A et al (2021) Handling imbalance classification virtual screening big data using machine learning algorithms. Complexity 2021:6675279. https:\/\/doi.org\/10.1155\/2021\/6675279","journal-title":"Complexity"},{"key":"833_CR14","doi-asserted-by":"publisher","first-page":"20220006","DOI":"10.1515\/jib-2022-0006","volume":"19","author":"D Baptista","year":"2022","unstructured":"Baptista D, Correia J, Pereira B, Rocha M (2022) Evaluating molecular representations in machine learning models for drug response prediction and interpretability. J Integr Bioinform 19:20220006. https:\/\/doi.org\/10.1515\/jib-2022-0006","journal-title":"J Integr Bioinform"},{"key":"833_CR15","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1021\/acs.molpharmaceut.4c00080","volume":"21","author":"JJ Lange","year":"2024","unstructured":"Lange JJ, Anelli A, Alsenz J et al (2024) Comparative analysis of chemical descriptors by machine learning reveals atomistic insights into solute\u2013lipid interactions. Mol Pharm 21:3343\u20133355. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00080","journal-title":"Mol Pharm"},{"key":"833_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12859-019-3135-4","volume":"20","author":"S Kwon","year":"2019","unstructured":"Kwon S, Bae H, Jo J, Yoon S (2019) Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinformatics 20:521. https:\/\/doi.org\/10.1186\/s12859-019-3135-4","journal-title":"BMC Bioinformatics"},{"key":"833_CR17","doi-asserted-by":"publisher","first-page":"50796","DOI":"10.1021\/acsomega.4c09356","volume":"9","author":"YN Fuadah","year":"2024","unstructured":"Fuadah YN, Pramudito MA, Firdaus L et al (2024) QSAR classification modeling using machine learning with a consensus-based approach for multivariate chemical hazard end points. ACS Omega 9:50796\u201350808. https:\/\/doi.org\/10.1021\/acsomega.4c09356","journal-title":"ACS Omega"},{"key":"833_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10822-024-00550-8","volume":"38","author":"JR Mora","year":"2024","unstructured":"Mora JR, Marquez EA, P\u00e9rez-P\u00e9rez N et al (2024) Rethinking the applicability domain analysis in QSAR models. J Comput Aided Mol Des 38:9. https:\/\/doi.org\/10.1007\/s10822-024-00550-8","journal-title":"J Comput Aided Mol Des"},{"key":"833_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11306-014-0733-z","volume":"11","author":"S O\u2032Hagan","year":"2015","unstructured":"O\u2032Hagan S, Swainston N, Handl J, Kell DB (2015) A \u2018rule of 0.5\u2019 for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics 11:323\u2013339. https:\/\/doi.org\/10.1007\/s11306-014-0733-z","journal-title":"Metabolomics"},{"key":"833_CR20","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/ph18121906","volume":"18","author":"SA Montenegro-Herrera","year":"2025","unstructured":"Montenegro-Herrera SA, Sosa A, Echeverri-Jim\u00e9nez I et al (2025) Machine learning-based QSAR screening of colombian medicinal flora for potential antiviral compounds against dengue virus: an in silico drug discovery approach. pharmaceuticals 18:1906. https:\/\/doi.org\/10.3390\/ph18121906","journal-title":"Pharmaceuticals"},{"key":"833_CR21","doi-asserted-by":"publisher","first-page":"P14","DOI":"10.1186\/1752-153X-2-S1-P14","volume":"2","author":"IV Tetko","year":"2008","unstructured":"Tetko IV, Tropsha A, Zhu H et al (2008) Comparison of applicability domains of QSAR models: application to the modelling of the environmental toxicity against Tetrahymena pyriformis. Chem Cent J 2:P14. https:\/\/doi.org\/10.1186\/1752-153X-2-S1-P14","journal-title":"Chem Cent J"},{"key":"833_CR22","doi-asserted-by":"publisher","DOI":"10.1021\/acsenvironau.5c00224","author":"J Komprda","year":"2026","unstructured":"Komprda J, L\u00f6rinczov\u00e1 K, Tou\u0161ov\u00e1 Z et al (2026) Methodological challenges in the application of QSAR models for chemical prioritization and toxicity assessment: a case study on aryl hydrocarbon receptor activity in environmental pollutant mixtures. ACS Environ Au. https:\/\/doi.org\/10.1021\/acsenvironau.5c00224","journal-title":"ACS Environ Au"},{"key":"833_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1752-0509-2-109","volume":"2","author":"K Raman","year":"2008","unstructured":"Raman K, Yeturu K, Chandra N (2008) targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2:109. https:\/\/doi.org\/10.1186\/1752-0509-2-109","journal-title":"BMC Syst Biol"},{"key":"833_CR24","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1021\/acs.jcim.5c01985","volume":"65","author":"J F\u00fcl\u00f6p","year":"2025","unstructured":"F\u00fcl\u00f6p J, \u0160\u00edcho M, Dehaen W (2025) TEMPL: a template-based protein\u2013ligand pose prediction baseline. J Chem Inf Model 65:11149\u201311157. https:\/\/doi.org\/10.1021\/acs.jcim.5c01985","journal-title":"J Chem Inf Model"},{"key":"833_CR25","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.jics.2025.101674","volume":"102","author":"G Nadh","year":"2025","unstructured":"Nadh G, Ahmed ARA M, et al (2025) Identification of high-affinity molecules from Sesbania grandiflora as potential therapeutic agents for oral ulcers- A multi-target-directed in silico approach. J Indian Chem Soc 102:101674. https:\/\/doi.org\/10.1016\/j.jics.2025.101674","journal-title":"J Indian Chem Soc"},{"key":"833_CR26","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake P, Bolz SN, Linnemann K, Schroeder M (2025) PLIP 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic Acids Res 53:W463\u2013W465. https:\/\/doi.org\/10.1093\/nar\/gkaf361","journal-title":"Nucleic Acids Res"},{"key":"833_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijtb.2023.03.003","volume":"70","author":"M Suresh","year":"2023","unstructured":"Suresh M, Naicker K, Solanki J et al (2023) Ligand-based pharmacophore modelling, virtual screening and docking studies to identify potential compounds against FtsZ of Mycobacterium tuberculosis. Indian J Tuberculosis 70:430\u2013444. https:\/\/doi.org\/10.1016\/j.ijtb.2023.03.003","journal-title":"Indian J Tuberculosis"},{"key":"833_CR28","doi-asserted-by":"publisher","first-page":"1403900","DOI":"10.3389\/fphar.2024.1403900","volume":"15","author":"M Chouhan","year":"2024","unstructured":"Chouhan M, Tiwari PK, Mishra R et al (2024) Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: a computational approach. Front Pharmacol 15: 1403900. https:\/\/doi.org\/10.3389\/fphar.2024.1403900","journal-title":"Front Pharmacol"},{"key":"833_CR29","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1080\/07391102.2023.2213341","volume":"42","author":"N Ponnusamy","year":"2024","unstructured":"Ponnusamy N, Pillai G, Arumugam M (2024) Computational investigation of phytochemicals identified from medicinal plant extracts against tuberculosis. J Biomol Struct Dyn 42:3382\u20133395. https:\/\/doi.org\/10.1080\/07391102.2023.2213341","journal-title":"J Biomol Struct Dyn"},{"key":"833_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/ph19020301","volume":"19","author":"Y Paerhati","year":"2026","unstructured":"Paerhati Y, Aikebaier A, Dilimulati D et al (2026) Rethinking Nature\u2019s Pharmacy: AI Era and Natural Product Drug Discovery. Pharmaceuticals 19:301. https:\/\/doi.org\/10.3390\/ph19020301","journal-title":"Pharmaceuticals"},{"key":"833_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3389\/fmicb.2018.01367","volume":"9","author":"D Machado","year":"2018","unstructured":"Machado D, Girardini M, Viveiros M, Pieroni M (2018) Challenging the drug-likeness dogma for new drug discovery in tuberculosis. Front Microbiol 9:1367. https:\/\/doi.org\/10.3389\/fmicb.2018.01367","journal-title":"Front Microbiol"},{"key":"833_CR32","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1039\/D4RA08362H","volume":"15","author":"RP Pakhariya","year":"2025","unstructured":"Pakhariya RP, Bhatnagar A, Pemawat G (2025) Quinoline analogs: multifaceted heterocyclic compounds with varied synthetic strategies and potent antitubercular properties. RSC Adv 15:3646\u20133663. https:\/\/doi.org\/10.1039\/D4RA08362H","journal-title":"RSC Adv"},{"key":"833_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/70300363","volume":"7","author":"M Dolezal","year":"2002","unstructured":"Dolezal M, Miletin M, Kunes J, Kralova K (2002) Substituted amides of pyrazine-2-carboxylic acids: synthesis and biological activity. Molecules 7:363\u2013373. https:\/\/doi.org\/10.3390\/70300363","journal-title":"Molecules"},{"key":"833_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/ph16030335","volume":"16","author":"L Fa\u00efon","year":"2023","unstructured":"Fa\u00efon L, Djaout K, Pintiala C et al (2023) Exploring the antitubercular activity of anthranilic acid derivatives: from MabA (FabG1) inhibition to intrabacterial acidification. Pharmaceuticals 16:335. https:\/\/doi.org\/10.3390\/ph16030335","journal-title":"Pharmaceuticals"},{"key":"833_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/ph16030377","volume":"16","author":"K Mehta","year":"2023","unstructured":"Mehta K, Khambete M, Abhyankar A, Omri A (2023) Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents. Pharmaceuticals 16:377. https:\/\/doi.org\/10.3390\/ph16030377","journal-title":"Pharmaceuticals"},{"key":"833_CR36","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1002\/mco2.353","volume":"4","author":"J Yang","year":"2023","unstructured":"Yang J, Zhang L, Qiao W, Luo Y (2023) Mycobacterium tuberculosis: pathogenesis and therapeutic targets. MedComm (Beijing) 4:e353. https:\/\/doi.org\/10.1002\/mco2.353","journal-title":"MedComm (Beijing)"},{"key":"833_CR37","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.chembiol.2015.09.011","volume":"22","author":"N Petronikolou","year":"2015","unstructured":"Petronikolou N, Nair SK (2015) Biochemical studies of mycobacterial fatty acid methyltransferase: a catalyst for the enzymatic production of biodiesel. Chem Biol 22:1480\u20131490. https:\/\/doi.org\/10.1016\/j.chembiol.2015.09.011","journal-title":"Chem Biol"},{"key":"833_CR38","doi-asserted-by":"publisher","first-page":"107250","DOI":"10.1016\/j.bioorg.2024.107250","volume":"146","author":"SK Wahan","year":"2024","unstructured":"Wahan SK, Bhargava G, Chawla V, Chawla PA (2024) Unlocking InhA: novel approaches to inhibit Mycobacterium tuberculosis. Bioorg Chem 146:107250. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107250","journal-title":"Bioorg Chem"},{"key":"833_CR39","doi-asserted-by":"publisher","first-page":"1725219","DOI":"10.3389\/fcimb.2025.1725219","volume":"15","author":"W Wang","year":"2026","unstructured":"Wang W, Bo X, Li M et al (2026) Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China. Front Cell Infect Microbiol 15:1725219. https:\/\/doi.org\/10.3389\/fcimb.2025.1725219","journal-title":"Front Cell Infect Microbiol"},{"key":"833_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejps.2017.12.013","volume":"114","author":"R Vos\u00e1tka","year":"2018","unstructured":"Vos\u00e1tka R, Kr\u00e1tk\u00fd M, Vin\u0161ov\u00e1 J (2018) Triclosan and its derivatives as antimycobacterial active agents. Eur J Pharm Sci 114:318\u2013331. https:\/\/doi.org\/10.1016\/j.ejps.2017.12.013","journal-title":"Eur J Pharm Sci"},{"key":"833_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejmech.2018.01.047","volume":"146","author":"A Chollet","year":"2018","unstructured":"Chollet A, Maveyraud L, Lherbet C, Bernardes-G\u00e9nisson V (2018) An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors. Eur J Med Chem 146:318\u2013343. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.047","journal-title":"Eur J Med Chem"},{"key":"833_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/biom9020068","volume":"9","author":"MA Prateeksha, Yusuf","year":"2019","unstructured":"Prateeksha, Yusuf MA, Singh BN et al (2019) Chrysophanol: a natural anthraquinone with multifaceted biotherapeutic potential. Biomolecules 9:68. https:\/\/doi.org\/10.3390\/biom9020068","journal-title":"Biomolecules"},{"key":"833_CR43","doi-asserted-by":"publisher","first-page":"103351","DOI":"10.1016\/j.jksus.2024.103351","volume":"36","author":"D Veeramuthu","year":"2024","unstructured":"Veeramuthu D, Savarimuthu I, Ali Khan I et al (2024) Antimycobacterial activity of plant compounds against extensively drug resistant (XDR-TB) Mycobacterium tuberculosis. J King Saud Univ Sci 36:103351. https:\/\/doi.org\/10.1016\/j.jksus.2024.103351","journal-title":"J King Saud Univ Sci"},{"key":"833_CR44","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.3390\/ijms25094886","volume":"25","author":"T Padayachee","year":"2024","unstructured":"Padayachee T, Lamb DC, Nelson DR, Syed K (2024) Structure\u2013function analysis of the essential Mycobacterium tuberculosis P450 drug target, CYP121A1. Int J Mol Sci 25:4886. https:\/\/doi.org\/10.3390\/ijms25094886","journal-title":"Int J Mol Sci"},{"key":"833_CR45","doi-asserted-by":"publisher","first-page":"7426","DOI":"10.1073\/pnas.0812191106","volume":"106","author":"P Belin","year":"2009","unstructured":"Belin P, Le Du MH, Fielding A et al (2009) Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc Natl Acad Sci 106:7426\u20137431. https:\/\/doi.org\/10.1073\/pnas.0812191106","journal-title":"Proc Natl Acad Sci"},{"key":"833_CR46","doi-asserted-by":"publisher","first-page":"113938","DOI":"10.1016\/j.bcp.2020.113938","volume":"177","author":"S Ortega Ugalde","year":"2020","unstructured":"Ortega Ugalde S, Wallraven K, Speer A et al (2020) Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis. Biochem Pharmacol 177:113938. https:\/\/doi.org\/10.1016\/j.bcp.2020.113938","journal-title":"Biochem Pharmacol"},{"key":"833_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.6026\/97320630013144","volume":"13","author":"P Pandey","year":"2017","unstructured":"Pandey P, Lynn AM, Bandyopadhyay P (2017) Identification of inhibitors against \u03b1-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM\/PBSA hybrid approach. Bioinformation 13:144\u2013148. https:\/\/doi.org\/10.6026\/97320630013144","journal-title":"Bioinformation"},{"key":"833_CR48","doi-asserted-by":"publisher","unstructured":"Stanley SA, Kawate T, Iwase N et al (2013) Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proceed Nat Acad Sci 110:11565\u201311570. https:\/\/doi.org\/10.1073\/pnas.1302114110","DOI":"10.1073\/pnas.1302114110"},{"key":"833_CR49","doi-asserted-by":"publisher","first-page":"21763","DOI":"10.1039\/D4RA02746A","volume":"14","author":"RZ Batran","year":"2024","unstructured":"Batran RZ, Sabt A, Dziadek J, Kassem AF (2024) Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti- Mycobacterium tuberculosis agents targeting enoyl acyl carrier protein reductase (InhA). RSC Adv 14:21763\u201321777. https:\/\/doi.org\/10.1039\/D4RA02746A","journal-title":"RSC Adv"},{"key":"833_CR50","doi-asserted-by":"publisher","first-page":"142074","DOI":"10.1016\/j.molstruc.2025.142074","volume":"1336","author":"MS Ebaid","year":"2025","unstructured":"Ebaid MS, Korycka-Machala M, Shaldam MA et al (2025) Exploring antitubercular activity of new coumarin derivatives targeting enoyl acyl carrier protein reductase (InhA): Synthesis, biological evaluation and computational studies. J Mol Struct 1336:142074. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142074","journal-title":"J Mol Struct"},{"key":"833_CR51","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.06288-11","volume":"56","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Yew WW, Barer MR (2012) Targeting persisters for tuberculosis control. Antimicrob Agents Chemother 56:2223\u20132230. https:\/\/doi.org\/10.1128\/AAC.06288-11","journal-title":"Antimicrob Agents Chemother"},{"key":"833_CR52","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1080\/07391102.2020.1797534","volume":"39","author":"J Verma","year":"2021","unstructured":"Verma J, Subbarao N (2021) Designing novel inhibitors against cyclopropane mycolic acid synthase 3 (PcaA): targeting dormant state of Mycobacterium tuberculosis. J Biomol Struct Dyn 39:6339\u20136354. https:\/\/doi.org\/10.1080\/07391102.2020.1797534","journal-title":"J Biomol Struct Dyn"},{"key":"833_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s11030-024-10967-w","volume":"28","author":"RV Chikhale","year":"2024","unstructured":"Chikhale RV, Pawar SP, Kolpe MS et al (2024) Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies. Mol Divers 28:1947\u20131964. https:\/\/doi.org\/10.1007\/s11030-024-10967-w","journal-title":"Mol Divers"},{"key":"833_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/bi0484163","volume":"44","author":"E Fioravanti","year":"2005","unstructured":"Fioravanti E, Adam V, Munier-Lehmann H, Bourgeois D (2005) The Crystal Structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3\u2018-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition. Biochemistry 44:130\u2013137. https:\/\/doi.org\/10.1021\/bi0484163","journal-title":"Biochemistry"},{"key":"833_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/life15020173","volume":"15","author":"S Konate","year":"2025","unstructured":"Konate S, Allangba KNPG, Fofana I et al (2025) Improved inhibitors targeting the thymidylate kinase of multidrug-resistant Mycobacterium tuberculosis with favorable pharmacokinetics. Life 15:173. https:\/\/doi.org\/10.3390\/life15020173","journal-title":"Life"},{"key":"833_CR56","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1074\/jbc.M209630200","volume":"278","author":"A Haouz","year":"2003","unstructured":"Haouz A, Vanheusden V, Munier-Lehmann H et al (2003) Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. J Biol Chem 278:4963\u20134971. https:\/\/doi.org\/10.1074\/jbc.M209630200","journal-title":"J Biol Chem"},{"key":"833_CR57","doi-asserted-by":"publisher","first-page":"12170","DOI":"10.1038\/s41598-024-63051-6","volume":"14","author":"M Singh","year":"2024","unstructured":"Singh M, Dhanwal A, Verma A et al (2024) Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis. Sci Rep 14:12170. https:\/\/doi.org\/10.1038\/s41598-024-63051-6","journal-title":"Sci Rep"},{"key":"833_CR58","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/j.1742-4658.2006.05481.x","volume":"273","author":"E Morgunova","year":"2006","unstructured":"Morgunova E, Illarionov B, Sambaiah T et al (2006) Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis. FEBS J 273:4790\u20134804. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05481.x","journal-title":"FEBS J"},{"key":"833_CR59","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1128\/AAC.00555-06","volume":"50","author":"JWP Teo","year":"2006","unstructured":"Teo JWP, Thayalan P, Beer D et al (2006) Peptide deformylase inhibitors as potent antimycobacterial agents. Antimicrob Agents Chemother 50:3665\u20133673. https:\/\/doi.org\/10.1128\/AAC.00555-06","journal-title":"Antimicrob Agents Chemother"},{"key":"833_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijantimicag.2009.04.005","volume":"34","author":"A Sharma","year":"2009","unstructured":"Sharma A, Sharma S, Khuller GK, Kanwar AJ (2009) In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. Int J Antimicrob Agents 34:226\u2013230. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.04.005","journal-title":"Int J Antimicrob Agents"},{"key":"833_CR61","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1016\/j.bmcl.2008.10.040","volume":"18","author":"A Pichota","year":"2008","unstructured":"Pichota A, Duraiswamy J, Yin Z et al (2008) Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results. Bioorg Med Chem Lett 18:6568\u20136572. https:\/\/doi.org\/10.1016\/j.bmcl.2008.10.040","journal-title":"Bioorg Med Chem Lett"},{"key":"833_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","volume":"21","author":"H Marrakchi","year":"2014","unstructured":"Marrakchi H, Lan\u00e9elle M-A, Daff\u00e9 M (2014) Mycolic acids: structures, biosynthesis, and beyond. Chem Biol 21:67\u201385. https:\/\/doi.org\/10.1016\/j.chembiol.2013.11.011","journal-title":"Chem Biol"},{"key":"833_CR63","doi-asserted-by":"publisher","first-page":"e53162","DOI":"10.1371\/journal.pone.0053162","volume":"8","author":"GD Coxon","year":"2013","unstructured":"Coxon GD, Craig D, Corrales RM et al (2013) Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues. PLoS ONE 8:e53162. https:\/\/doi.org\/10.1371\/journal.pone.0053162","journal-title":"PLoS ONE"},{"key":"833_CR64","doi-asserted-by":"publisher","first-page":"19321","DOI":"10.1074\/jbc.M809599200","volume":"284","author":"J Vaubourgeix","year":"2009","unstructured":"Vaubourgeix J, Bardou F, Boissier F et al (2009) S-Adenosyl-N-decyl-aminoethyl, a Potent Bisubstrate Inhibitor of Mycobacterium tuberculosis Mycolic Acid Methyltransferases. J Biol Chem 284:19321\u201319330. https:\/\/doi.org\/10.1074\/jbc.M809599200","journal-title":"J Biol Chem"},{"key":"833_CR65","doi-asserted-by":"publisher","unstructured":"Montgomery MG, Petri J, Spikes TE, Walker JE (2021) Structure of the ATP synthase from Mycobacterium smegmatis provides targets for treating tuberculosis. Proceeding Nat Acad Sci 118:e2111899118. https:\/\/doi.org\/10.1073\/pnas.2111899118","DOI":"10.1073\/pnas.2111899118"},{"key":"833_CR66","doi-asserted-by":"publisher","first-page":"e08482","DOI":"10.1016\/j.heliyon.2021.e08482","volume":"7","author":"MA Isa","year":"2021","unstructured":"Isa MA, Abubakar MB, Mohammed MM et al (2021) Identification of potent inhibitors of ATP synthase subunit c (AtpE) from Mycobacterium tuberculosis using in silico approach. Heliyon 7:e08482. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08482","journal-title":"Heliyon"},{"key":"833_CR67","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/S2666-5247(24)00149-6","volume":"5","author":"ES Shaw","year":"2024","unstructured":"Shaw ES, Stoker NG, Potter JL et al (2024) Bedaquiline: what might the future hold? Lancet Microbe 5:100909. https:\/\/doi.org\/10.1016\/S2666-5247(24)00149-6","journal-title":"Lancet Microbe"},{"key":"833_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s44337-025-00493-5","volume":"2","author":"YM Kyaw","year":"2025","unstructured":"Kyaw YM, Linn YH (2025) Overview on adverse effects of bedaquiline containing regimens for drug resistant tuberculosis. Discover Med 2:241. https:\/\/doi.org\/10.1007\/s44337-025-00493-5","journal-title":"Discover Med"},{"key":"833_CR69","doi-asserted-by":"publisher","first-page":"e1500106","DOI":"10.1126\/sciadv.1500106","volume":"1","author":"L Preiss","year":"2015","unstructured":"Preiss L, Langer JD, Yildiz \u00d6 et al (2015) Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline. Sci Adv 1:e1500106. https:\/\/doi.org\/10.1126\/sciadv.1500106","journal-title":"Sci Adv"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00833-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00833-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:47:07Z","timestamp":1778482027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00833-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00833-2","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial or non-financial interests related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"116"}}